Your browser doesn't support javascript.
loading
Phase 2 study of bevacizumab plus carboplatin/nab-paclitaxel followed by bevacizumab plus nab-paclitaxel for non-squamous non-small cell lung cancer with malignant pleural effusion.
Tamiya, Motohiro; Tamiya, Akihiro; Suzuki, Hidekazu; Taniguchi, Yoshihiko; Katayama, Kanako; Minomo, Shojiro; Nakao, Keiko; Takeuchi, Naoko; Matsuda, Yoshinobu; Naito, Yujiro; Shiroyama, Takayuki; Okamoto, Norio; Okishio, Kyoichi; Kumagai, Toru; Atagi, Shinji; Imamura, Fumio; Hirashima, Tomonori.
Afiliação
  • Tamiya M; Department of Thoracic Oncology, Osaka International Cancer Institute, Chuo-ku Otemae 3-1- 69, Osaka City, Osaka, 541-8567, Japan. moto19781205@yahoo.co.jp.
  • Tamiya A; Department of Thoracic Oncology, Kinki-Chuo Chest Medical Center, Kitaku Nagasone-cho 1180, Sakai City, Osaka, 591-8555, Japan.
  • Suzuki H; Department of Thoracic Malignancy, Osaka Habikino Medical Center, Habikino 3-7-1, 583-8588, Habikino City, Osaka, Japan.
  • Taniguchi Y; Department of Thoracic Oncology, Kinki-Chuo Chest Medical Center, Kitaku Nagasone-cho 1180, Sakai City, Osaka, 591-8555, Japan.
  • Katayama K; Department of Thoracic Oncology, Kinki-Chuo Chest Medical Center, Kitaku Nagasone-cho 1180, Sakai City, Osaka, 591-8555, Japan.
  • Minomo S; Department of Thoracic Oncology, Kinki-Chuo Chest Medical Center, Kitaku Nagasone-cho 1180, Sakai City, Osaka, 591-8555, Japan.
  • Nakao K; Department of Thoracic Oncology, Kinki-Chuo Chest Medical Center, Kitaku Nagasone-cho 1180, Sakai City, Osaka, 591-8555, Japan.
  • Takeuchi N; Department of Thoracic Oncology, Kinki-Chuo Chest Medical Center, Kitaku Nagasone-cho 1180, Sakai City, Osaka, 591-8555, Japan.
  • Matsuda Y; Department of Thoracic Oncology, Kinki-Chuo Chest Medical Center, Kitaku Nagasone-cho 1180, Sakai City, Osaka, 591-8555, Japan.
  • Naito Y; Department of Respiratory Medicine and Clinical Immunology, Osaka University, Yamadaoka 2-15, 565-0871, Suita City, Osaka, Japan.
  • Shiroyama T; Department of Respiratory Medicine and Clinical Immunology, Osaka University, Yamadaoka 2-15, 565-0871, Suita City, Osaka, Japan.
  • Okamoto N; Department of Thoracic Malignancy, Osaka Habikino Medical Center, Habikino 3-7-1, 583-8588, Habikino City, Osaka, Japan.
  • Okishio K; Department of Clinical Research Center, Kinki-Chuo Chest Medical Center, Kitaku Nagasone- cho 1180, Sakai City, Osaka, 591-8555, Japan.
  • Kumagai T; Department of Thoracic Oncology, Osaka International Cancer Institute, Chuo-ku Otemae 3-1- 69, Osaka City, Osaka, 541-8567, Japan.
  • Atagi S; Department of Clinical Research Center, Kinki-Chuo Chest Medical Center, Kitaku Nagasone- cho 1180, Sakai City, Osaka, 591-8555, Japan.
  • Imamura F; Department of Thoracic Oncology, Osaka International Cancer Institute, Chuo-ku Otemae 3-1- 69, Osaka City, Osaka, 541-8567, Japan.
  • Hirashima T; Department of Thoracic Malignancy, Osaka Habikino Medical Center, Habikino 3-7-1, 583-8588, Habikino City, Osaka, Japan.
Invest New Drugs ; 39(4): 1106-1112, 2021 08.
Article em En | MEDLINE | ID: mdl-33544282
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Pulmao Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Derrame Pleural Maligno / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Pulmao Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Derrame Pleural Maligno / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão